MICA/BxB7H3 NKE(Xencor)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameMICA/BxB7H3 NKE(Xencor)

Drug Alias NameMICA/B x B7H3 NKE bispecific antibody

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-CD276Anti-MICAAnti-MICB

TargetsCD276 antigenMHC class I polypeptide-related sequence AMHC class I polypeptide-related sequence B

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesXencor Inc

China Registration ClassN/A

Develop Information

Active CompaniesXencor Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A